Thrombolytic therapy and fatal pulmonary emboli.
D003911:Dextrans / Q000627:therapeutic use; D005343:Fibrinolytic Agents / Q000009:adverse effects*; D006493:Heparin / Q000627:therapeutic use*; D011655:Pulmonary Embolism / Q000139:chemically induced*; D013924:Thrombophlebitis / Q000188:drug therapy*
D003911:Dextrans; D005343:Fibrinolytic Agents; D006493:Heparin